Products for Research Use Only
RegisterLogin

TTA-A8

CAT: 0804-HY-14232-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-14232-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TTA-A8 (Compound 13) is a short-acting T-type calcium channel antagonist with oral activity, exhibiting an IC50 value of 31.3 nM in the FLIPR depolarization assay. TTA-A8 possesses favorable pharmacokinetic properties, making it suitable for research on epilepsy and sleep[1].
CAS Number
1146395-46-1
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tta-a8.html
Solubility
10 mM in DMSO
Smiles
CC1=NC=CN=C1C2=CC=C(C=C2)CC(N[C@@H](C3=CC=C(C=N3)OCC(F)(F)F)C)=O
Molecular Formula
C22H21F3N4O2
Molecular Weight
430.42
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Yang Z Q, et al. Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents[J]. ACS Medicinal Chemistry Letters, 2010, 1 (9) : 504-509.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1

Related Products

CatalogName
HY-10955TTA-P1
HY-111828-01TTA-A2
HY-10388-01TTA-Q6
HY-10035-01TTA-P2
HY-50707-01(Rac) -TTA-P2
HY-10035RTTA-P2 (Standard)
HY-10035A-01(R) -TTA-P2
HY-10388A-01TTA-Q6 (isomer)
HY-N15421Leucomycin A8
HY-P11052A8 peptide

Alternative Products

CatalogName
MBS5814492TTA-A8
BA6572-1TTA-A2
MBS5805090TTA-P2
MBS5754065TTA-Q6
T61747-01TTA-P1

Popular Products